Celsion Corporation Enters into $10M Strategic Loan Facility with Silicon Valley Bank
Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, announces it has entered into a $10 million loan facility with Silicon Valley